| Peer-Reviewed

An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality

Received: 21 April 2020    Accepted: 11 May 2020    Published: 28 May 2020
Views:       Downloads:
Abstract

According to the WHO report of 2014, 5 people die every minute and 7,671 persons die each day from obesity related complications in the world [36]. Overweight and obesity are the fifth leading risks for global deaths. In June 2013, the American Medical Association recognized obesity as an epidemic. In Cameroon, the prevalence in 2014 stood at 9.6%, second highest in CEMAC after Gabon 15% (WHO 2014). Following this background, the main objective of this paper is to assess the financial cost and benefits and the Average Cost-Benefit Ratio (ACBR) of obesity treatment in the Bamenda Municipality. Specifically, this paper compares the cost and benefit of obesity treatment and calculates the average cost-benefit Ratio of obesity treatment. To ascertain this objective, use is made of exploratory, descriptive and primary and secondary data is employed. Primary data was collected from 100 hypertensive and 100 diabetes individuals age 20 and above from the Bamenda general hospital. Used was also made of information collected during a six month participatory observation at 2 separate gyms. Secondary data was gotten from WHO and National Cancer Institute. Results show a yearly cost of obesity treatment of 492,000 and a yearly benefit of obesity treatment of 6,677,250 giving a net benefit of 6,185,250fcfa for treating obesity annually. The results also give an ACBR of 0.07 indicating a weight loss project is worthwhile. From the findings we recommend a massive sensitization on the consequences of obesity and the creation of an obesity rehabilitation centre for those who lack motivation and discipline needed to treat obesity.

Published in Central African Journal of Public Health (Volume 6, Issue 4)
DOI 10.11648/j.cajph.20200604.11
Page(s) 180-191
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Diabetes, Hypertension, Cancer, CVD and BMI

References
[1] Blouin, C. (2014) The economic impact of obesity and overweight. Summaries by the Nutrition–Physical Activity–Weight Team, Issue 9.
[2] Burkhauser, RV. and Cawley J. (2008). Beyond BMI: the Value of More Accurate Measures of Fatness and Obesity in Social Science research. Journal of Health Economics.
[3] DHS. (2011). Demographic Health Survey and Multiple Indicators.www.dhsprogram.org.
[4] Eckel, R. H. (1997). A Statement for Healthcare Professionals From the Nutrition Committee. American Heart Association, https://doi.org/10.1161/01. CIR. 96.9.3248 Circulation. 1997; 96: 3248-3250.
[5] Fast Facts of Obesity. (2006). Economic Costs of Obesity on Health Care. A project of the Trust for America Health and the Robert Wood Johnson Foundation.
[6] Finkelstein EA., Trogdon JG. Cohen JW and Dietz W. (2009). Annual Medical Spending Attributable to Obesity. Payer- and Service-specific Estimates. Health Affairs, 28 (5): w822-831.
[7] Gatineau Mary. (2014). Adult obesity and type 2 diabetes. Public Health England 133. PHE publications gateway number: 2014211.
[8] Grossman, M. (1972a). The Concept of Health Capital and the Demand for Health. Journal of Political Economy, 80 (2): 223–255, doi: 10.1086/259880.
[9] Growth and Employment strategy. (2010). Reference Framework for government action over period 2010-2020. Cameroon.sector strategy monetoring metrice.
[10] Health Sector Strategy Paper. (2001). The Health sector strategy paper 2001-2015. Cameroon Report. www. Minsante.cm.
[11] Hendrick, B.. (2011). Obesity Increases Risk of Deadly Heart Attacks. WebMD Archives.
[12] Jingi Ahmadou M, Noubiap, J. J., Nansseu, J. R., Wang, B., Kingue, S., and Kengne. (2014). Access to Diagnostic Tests and Essential Medicines for Cardiovascular Diseases and Diabetes Care: Cost, Availability and Affordability in the West Region of Cameroon. Published online 2014 Nov 4. doi: 10.1371/journal.pone.0111812.
[13] Johannesson M and Fagerberg B. (1992). A health-economic comparison of diet and drug treatment in obese men with mild hypertension. PMID: 1328366.
[14] Justin B and Andre P ((2011). Chronic non-communicable diseases in Cameroon - burden, determinants and current policies. Global Health Journal, 44.
[15] JV Neel. (1962). Diabetes millitus: genotype redered detrimental by "progress"? Americn journal of Human Genethics.
[16] KonnopkaA., Bödemann M. and König H. (2011). Health burden and costs of obesity and overweight in Germany. The European Journal of Health Economics Vol. 12, No. 4 August, pp. 345-352.
[17] Lewis Landsberg, Louis J., Lawrence J., Valerie Burke, Donald Lloyd-Jones and James Sower, (2013). Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment. Journal of clinical hypertension. Volume 15, Issue 1, Pages 14–33.
[18] Lindeboom M, Lunborg P and Van Der Klaauw B. (2010). Assessing the impact of obesity on labor market outcomes. Journal of Public Medicine. Elsevier B. V., 20864420.
[19] Manga Simon, Kanjo M, Ngwa W (2017). Challenges with Cervical Cancer Treatment in Cameroon. Obstet Gynecol Cases Rev 2017, 4: 104.
[20] MDG. (2010). Millennium Development Goals, Internet: http://www.planning.gov.mv. Maldives Country Repo: Department of National Planning, Ministry of Finance and Treasury.
[21] National Cancer Institute. (2012). Obesity and Cancer Risk.journal of National cancer institute.
[22] National institute of public health Quebec. (2014) htts://www.ins pq.qc.ca.
[23] Ndi, N. (2010). Treatment for cancer too costly for an average Cameroonian. Vanguard Cameroon.
[24] Ndumbe, P. M. 1998. "Benchmarks" and Health reforms in Cameroon. British Medical Journal.
[25] Nouetchognou, u. S. 2015. The Silent Epidemic: Non-communicable diseases in Cameroon. Journal of Foretia Foundation.
[26] Obesity, Physical Activity and Diet. (2013). England statistics report.
[27] Price Adi J.. (2011). Cancer care challenges in developing countries. cancer volumn 118 issue 14.
[28] Rigby and James, P. (2003). Waiting for a green light for health? Europe at the crossroads for diet and disease. Obesity task Force Possition Paper, London, NWI2NS.
[29] Runge, C. F. 2007. Economic Consequences of the Obese. Health Affairs journal. Diabetes.; 56 (11): 2668-2672..
[30] SDG. (2010). Sustainable Development Goals. Cameroon. www.un.org.
[31] Sobal, Jeffery, and Albert J. Stunkard. (1989). Socioeconomic Status and Obesity: A Review of the Literature.."Psychological Bulletin, 105.
[32] Surg, W. (1998). Cost-benefit analysis for the treatment of severe obesity. Journal of Public Medicine. Sep; 22 (9): 1008-17. PMID: 9717430.
[33] Tanya A. N. K., Lantum D. A. and Tanya V. N. 2011. Nutrition and Public Health in Cameroon: Combating the Crisis. Cameroon Academy of Sciences, Yaoundé, Cameroon.
[34] Wang L. Y. Yang Q., Lowry R. and wester H (2003). Economic Analysis of a School-Based Obesity Prevention Program. Pub med journal DOI: 10.1038/oby.2,178.
[35] WHO. (2012). Facts and Figures of obesity and overweight. www.who.int.
[36] WHO. (2013). Obesity Facts & Figures. Fack Sheet on Obesity Facts and Figures, N°311. www.who.int.
[37] WHO. (2014). obesity facts and figures. www.who.int, 311.
[38] World Bank. (2010). Facks and Figures of Overweight and Obesity data.worldbank.org..
[39] Yates J andMurphy C. (2006). A cost benefit analysis of weight management strategies. USA: National Library of Medicine National Institutes of Health.
Cite This Article
  • APA Style

    Kinga Bertila Mayin, Sundjo Fabien, Nfor Omarine Nlinwe, Njimanted Godfrey Forgha. (2020). An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality. Central African Journal of Public Health, 6(4), 180-191. https://doi.org/10.11648/j.cajph.20200604.11

    Copy | Download

    ACS Style

    Kinga Bertila Mayin; Sundjo Fabien; Nfor Omarine Nlinwe; Njimanted Godfrey Forgha. An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality. Cent. Afr. J. Public Health 2020, 6(4), 180-191. doi: 10.11648/j.cajph.20200604.11

    Copy | Download

    AMA Style

    Kinga Bertila Mayin, Sundjo Fabien, Nfor Omarine Nlinwe, Njimanted Godfrey Forgha. An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality. Cent Afr J Public Health. 2020;6(4):180-191. doi: 10.11648/j.cajph.20200604.11

    Copy | Download

  • @article{10.11648/j.cajph.20200604.11,
      author = {Kinga Bertila Mayin and Sundjo Fabien and Nfor Omarine Nlinwe and Njimanted Godfrey Forgha},
      title = {An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality},
      journal = {Central African Journal of Public Health},
      volume = {6},
      number = {4},
      pages = {180-191},
      doi = {10.11648/j.cajph.20200604.11},
      url = {https://doi.org/10.11648/j.cajph.20200604.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20200604.11},
      abstract = {According to the WHO report of 2014, 5 people die every minute and 7,671 persons die each day from obesity related complications in the world [36]. Overweight and obesity are the fifth leading risks for global deaths. In June 2013, the American Medical Association recognized obesity as an epidemic. In Cameroon, the prevalence in 2014 stood at 9.6%, second highest in CEMAC after Gabon 15% (WHO 2014). Following this background, the main objective of this paper is to assess the financial cost and benefits and the Average Cost-Benefit Ratio (ACBR) of obesity treatment in the Bamenda Municipality. Specifically, this paper compares the cost and benefit of obesity treatment and calculates the average cost-benefit Ratio of obesity treatment. To ascertain this objective, use is made of exploratory, descriptive and primary and secondary data is employed. Primary data was collected from 100 hypertensive and 100 diabetes individuals age 20 and above from the Bamenda general hospital. Used was also made of information collected during a six month participatory observation at 2 separate gyms. Secondary data was gotten from WHO and National Cancer Institute. Results show a yearly cost of obesity treatment of 492,000 and a yearly benefit of obesity treatment of 6,677,250 giving a net benefit of 6,185,250fcfa for treating obesity annually. The results also give an ACBR of 0.07 indicating a weight loss project is worthwhile. From the findings we recommend a massive sensitization on the consequences of obesity and the creation of an obesity rehabilitation centre for those who lack motivation and discipline needed to treat obesity.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - An Evaluation of the Financial Cost-Benefit Analysis and Acbr of Obesity Treatment in the Bamenda Municipality
    AU  - Kinga Bertila Mayin
    AU  - Sundjo Fabien
    AU  - Nfor Omarine Nlinwe
    AU  - Njimanted Godfrey Forgha
    Y1  - 2020/05/28
    PY  - 2020
    N1  - https://doi.org/10.11648/j.cajph.20200604.11
    DO  - 10.11648/j.cajph.20200604.11
    T2  - Central African Journal of Public Health
    JF  - Central African Journal of Public Health
    JO  - Central African Journal of Public Health
    SP  - 180
    EP  - 191
    PB  - Science Publishing Group
    SN  - 2575-5781
    UR  - https://doi.org/10.11648/j.cajph.20200604.11
    AB  - According to the WHO report of 2014, 5 people die every minute and 7,671 persons die each day from obesity related complications in the world [36]. Overweight and obesity are the fifth leading risks for global deaths. In June 2013, the American Medical Association recognized obesity as an epidemic. In Cameroon, the prevalence in 2014 stood at 9.6%, second highest in CEMAC after Gabon 15% (WHO 2014). Following this background, the main objective of this paper is to assess the financial cost and benefits and the Average Cost-Benefit Ratio (ACBR) of obesity treatment in the Bamenda Municipality. Specifically, this paper compares the cost and benefit of obesity treatment and calculates the average cost-benefit Ratio of obesity treatment. To ascertain this objective, use is made of exploratory, descriptive and primary and secondary data is employed. Primary data was collected from 100 hypertensive and 100 diabetes individuals age 20 and above from the Bamenda general hospital. Used was also made of information collected during a six month participatory observation at 2 separate gyms. Secondary data was gotten from WHO and National Cancer Institute. Results show a yearly cost of obesity treatment of 492,000 and a yearly benefit of obesity treatment of 6,677,250 giving a net benefit of 6,185,250fcfa for treating obesity annually. The results also give an ACBR of 0.07 indicating a weight loss project is worthwhile. From the findings we recommend a massive sensitization on the consequences of obesity and the creation of an obesity rehabilitation centre for those who lack motivation and discipline needed to treat obesity.
    VL  - 6
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Health Economics and Policy Management, Faculty of Business and Management Sciences, Catholic University of Cameroon (CATUC) Bamenda, Bamenda, Cameroon

  • Department of Economics, Higher Teacher Training College, University of Bamenda, Bamenda, Cameroon

  • Department of Medical Laboratory Science, Faculty of Health Sciences, The University of Bamenda, Bamenda, Cameroon

  • Department of Management Sciences, Higher Institute of Commerce and Managementigher Institute of Commence and Management, University of Bamenda, Bamenda, Cameroon

  • Sections